CLINICAL_TRIALS
withdrawal
· 2022-05-03
Clinical Trial Update: Topical Morphine for Analgesia in Patients With Skin Grafts [Phase 3]
Summary
A Phase 3 trial evaluating topical morphine for analgesia in skin graft patients was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Rambam Health Care Campus | Conditions: Skin Transplantation, Pain | Phase 3 | Status: WITHDRAWN